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Histone Deacetylase 1 Inactivation
by an Adenovirus Early Gene Product
CBF, GROUCHO, Sp1, and the Epstein-Barr virus nu-
clear antigen 3C (EBNA3C), have been shown to recruit
HDACs to specific promoters, thereby repressing tran-
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Gam1 expression was previously found to increaseand Matt Cotten4
1Department of Experimental Oncology cell survival; this study also identified a mutant, Gam1
L 258,265 A (Gam1mt), in which two leucine-to-alanineEuropean Institute of Oncology
20141 Milan changes impaired the protective function of Gam1 [7].
Recently, Gam1-mediated induction of heat-shock re-Italy
2Division of Molecular Biology sponse in the host cell was shown to be crucial for viral
replication [1].Institute of Medical Biochemistry
University of Vienna To assess if Gam1 could upregulate transcription, we
transfected cells with a RSV LTR-driven luciferase re-Vienna Biocenter
3Institute of Microbiology porter gene plus plasmids directing expression of Gam1,
Gam1mt, or HDAC1. Gam1 expression resulted in a 4- toUniversity of Innsbruck
4Institute for Molecular Pathology 6-fold induction of the RSV LTR (Figure 1A, lanes 1, 3,
and 4). Gam1mt was essentially inactive in this assay (laneVienna
Austria 5). Gam1 also activated a variety of other promoters,
including the hsp70 promoter [8] (Figure 1B).
HDAC1 can act as a negative regulator of the RSV
promoter [9] (Figure 1A, lanes 1 and 2). Upon cotrans-Summary
fecting Gam1 and HDAC1, we observed a substantial
relief of HDAC-mediated repression (Figure 1A, lane 6).Gam1 is an early gene product of the avian adenovirus
CELO and is essential for viral replication [1]. Gam1 HDAC repression was alleviated both by the deacetylase
inhibitor TSA and by Gam1 (Figure 1C, lane 6 and 7),has no homology to any known proteins; however, its
early expression and nuclear localization suggest that although TSA was a more potent transcriptional activa-
tor than Gam1 in this assay (Figure 1C). When addedthe protein functions to influence transcription in the
infected cell. A determinant of eukaryotic gene expres- together with TSA, Gam1 was unable to stimulate tran-
scription further, indicating a similar mechanism of ac-sion is the acetylation state of chromosomal histones
and other nuclear proteins [2]. We find that Gam1 ex- tion. Gam1 expression elevates the cellular levels of
heat shock proteins 70 and 40 (hsp70, hsp40) [1]. Uponpression increases the level of transcription from a
variety of eukaryotic promoters, similar to the effect treating cells with increasing amounts of TSA, we found
that both hsp70 and hsp40 expression increased, againof treating cells with the histone deacetylase (HDAC)
inhibitor trichostatin A (TSA [3]). We show that Gam1 suggesting a similar mode of action (Figure 1D). These
results are in agreement with previous findings on thecan effectively inhibit histone deacetylation by HDAC1
and that Gam1 binds to HDAC1 both in vitro and in vivo. regulation of hsp70 [10]. Taken together, these data
support the hypothesis that Gam1 expression increasesA CELO virus lacking Gam1 (CELOdG) is replication
defective [1], but the defect can be overcome by either the transcriptional activity of a variety of promoter com-
plexes by influencing their acetylation state.expressing an interfering HDAC1 mutant or by treating
infected cells with TSA. The identification of a viral To test whether Gam1 directly interferes with HDAC
early gene product having the specific function of activity, we used an in vitro HDAC1 assay with purified
binding and inactivating HDAC suggests that deacety- recombinant proteins (Figure 2). Gam1 strongly inhibited
lase complexes play an important role in limiting early HDAC activity. At a Gam1 concentration of 50 nM, the
gene expression from invading viruses. inhibition was comparable to that obtained with TSA at
3 nM (Figure 2A). The Gam1mt protein was significantly
Results and Discussion less effective than wild-type (Figure 2A). As shown in
Figure 3F, Gam1mt has reduced binding to HDAC1. Gam1
Regulation of nuclear protein acetylation is emerging as expression also inhibited the HDAC activity harvested by
an important mechanism for controlling gene expres- immunoprecipitating transfected cells (data not shown).
sion, and a general correlation between the acetylation We then tested whether Gam1 would directly interact
of histones or other nuclear proteins and gene activity with HDAC1 (Figure 3), using recombinant HDAC1 wild-
has been established. Reversible acetylation of histones type and deletion constructs (Figure 3A) in GST-fusion
is controlled by histone acetylases and deacetylases. protein pull-down assays. In vitro translated Gam1
Recently, transcriptional regulators involved in cell cycle bound to GST-HDAC1 but not to the GST control (Figure
regulation, growth control, differentiation and develop- 3B). In addition to GST-HDAC1, GST-HDAC2 and GST-
ment, such as MAD, YY1, N-COR/SMRT, the retinoblas- HDAC3 also bind Gam1 (Figure 3D), suggesting that
toma protein pRb, and related pocket proteins, MeCP2, class I HDAC members share the ability to interact with
Gam1. The homology between these HDACs is concen-
trated within the amino-terminal 300 residues of the pro-5 Correspondence: schiocca@ieo.it
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Figure 1. Gam1 and TSA
(A) Gam1 upregulates the RSV LTR promoter. COS cells were transfected with 0.5 g RSV LTR-driven luciferase reporter gene (lane 1) plus
1.5 g HDAC1 (lanes 2, 6, and 7) plus 0.1 g Gam1 (lane 3) plus 0.5 g Gam1 (lanes 4 and 6) plus 0.5 g Gam1mt (lanes 5 and 7). The same
amount of promoter was added, and a total amount of 3.5 g of DNA was transfected in each case (pBSK was added as an empty vector).
Cell lysates were analyzed for luciferase activity, and the values represent luciferase activity (average of four measurements, standard deviation
indicated).
(B) Gam1 upregulates a variety of eukaryotic promoters and its own promoter within the CELO genome [19]. COS cells were transfected with
0.5 g AdE4Cat construct (lane1) plus 0.5 g Gam1 (lane 2); 0.5 g CMV -galactosidase construct (lane 3) plus 0.5 g Gam1 (lane 4); 0.5
g SV40 -galactosidase construct (lane 5) plus 0.5 g Gam1 (lane 6); 0.5 g CELOGam1 promoter luciferase construct (lane 7) plus 0.5 g
Gam1 (lane 8); 0.5 g hsp-70 promoter luciferase construct [8] (lane 9) plus 0.5 g Gam1 (lane 10). A total amount of 3.5 g of DNA was
transfected in each case (pBSK was added as an empty vector). Cell lysates were analyzed for gene reporter activity, and the values represent
the average of three measurements, standard deviation indicated.
(C) Gam1 upregulates the RSV LTR promoter like TSA. COS cells were transfected with 0.5 g RSV LTR-driven luciferase reporter gene (lane
1) plus 0.5 g Gam1 (lanes 3, 4, 7, and 8) plus 1 g HDAC1 (lanes 5, 6, 7, and 8). The same amount of promoter was added, and a total
amount of 3 g of DNA was transfected in each case (pBSK was added as an empty vector). After a 24 hr transfection period, fresh medium
was applied; samples 2, 4, 6, and 8 contained in addition 30 ng/ml TSA. Lysates prepared at 48 hr posttransfection were analyzed for luciferase
activity (average of three measurements, standard deviation indicated).
(D) TSA elevates heat shock protein 40 and heat shock protein 70 levels similar to Gam1 [1]. HepG2 cells were treated for 24 hr with the
indicated amount of TSA, and cell extracts were immunoblotted for hsp40, hsp70, and tubulin.
teins, and mutations within this region dramatically re- lowed by immunoblotting demonstrated that endoge-
nous HDAC1 interacts with Gam1 but not with a controlduce enzymatic activity [11–13]. In agreement with this,
we found that the first 53 amino acid residues of HDAC1 protein (E1B-19K) (Figure 3G) or with a control antibody
(data not shown). Similar results were obtained usingwere sufficient for the interaction with Gam1 (Figure 3B,
GST-HDAC 1–53), whereas HDAC mutants 54–303 and U2OS cells. We could also detect HDAC1 coprecipita-
tion with Gam1 upon transfecting cells with an HDAC1-303–482 showed no detectable interaction (Figure 3B).
Thus, the HDAC1 domain sufficient for interaction with Flag construct and immunoprecipitating with a Flag anti-
body (data not shown).Gam1 encompasses HDAC1 amino acids 1–53, a region
which is also important for dimerization and enzymatic Gam1 is required for CELO replication, with a Gam1-
negative CELO (CELOdG) displaying 104 - to 106 -foldactivity of HDAC1 [13]. Interestingly, this region is absent
in class II deacetylases [14]. As expected, Gam1 did not lower replication capacity than wild-type CELO in vivo
[1]. If Gam1 is functioning as an inhibitor of HDAC activityassociate with class II deacetylases (data not shown).
To assess whether Gam1 can interact with endoge- and this inhibition is essential for viral replication, then
alternate methods of interfering with HDAC activity mightnous HDAC1, we expressed myc-tagged Gam1 in HeLa
cells. Immunoprecipitation with anti-HDAC1 serum fol- replace the need for Gam1. Thus, we tested the ability of
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Figure 2. Gam1 Inhibits HDAC1 Enzymatic
Activity
(A and B) Activity assays were performed in
25 l, using baculovirus-expressed purified
HDAC1 (20 ng) preincubated with the indi-
cated amounts of E. coli-expressed purified
HIS-Gam1 wt and HIS-Gam1mt. Input and
TSA-incubated reactions were included as
controls (TSA 1 ng/ml). (A) Increasing
amounts of GAM1wt lead to a nearly com-
plete inhibition of HDAC enzymatic activity
(average of six independent experiments). (B)
Western blot indicating the amount of purified
protein used for HDAC1 in vitro assay in (A).
either an HDAC1 mutant (D174H) that is still able to dimer- to replace Gam1 in CELO replication, supporting the
conclusion that an essential function of Gam1 in CELOize with class I enzymes while having lost its catalytic
activity [13], or a chemical deacetylase inhibitor, TSA, to replication is to inhibit HDAC activity.
We have presented evidence that Gam1, an avianreplace Gam1 in CELOdG replication. CELOdG contains
an active luciferase expression unit in place of the dis- adenovirus early gene product, binds to HDAC1 and
inactivates it, thus accounting for the transcriptional ac-rupted Gam1 gene, and the growth of this virus can
be monitored by the expression of luciferase through tivation function of Gam1. The ability of Gam1 expres-
sion to modulate heat shock protein expression [1] andmultiple passages of the virus. Infection of LMH cells
with CELOdG resulted in luciferase expression in the the observation that TSA upregulates both hsp70 and
hsp40 expression similar to Gam1 provide a biologicalfirst passage, which diminished to background after
three passages, indicating that the virus is unable to function for the inhibition of deacetylase by Gam1. This
direct inhibition of deacetylase by a viral protein repre-replicate (Figures 4A and 4B). Inclusion of a recombinant
adenovirus directing expression of the HDAC mutant sents a novel form of gene regulation. Furthermore, the
severe block in replication of the Gam1-negative virusat each passage allowed CELOdG replication, while a
control adenovirus in the same vector background but demonstrates that cellular deacetylases represent an
important barrier to the establishment of viral infection.expressing EGFP failed to give long-term complementa-
tion (Figure 4A). A recombinant adenovirus expressing The idea that deacetylase may serve as a cellular de-
fense against viruses is relatively new. However, therewild-type HDAC1 provided a modest complementation
of CELOdG viral growth, probably due to overexpressed are accumulating data that deacetylase is part of the
mechanism of silencing integrated retroviral provirusesdeacetylase interfering with endogenous deacetylase
activity. Indeed, independent experiments demon- (see, for example, [15]). The bovine herpesvirus 1 en-
codes a deacetylase binding protein that may be impor-strated that, although HDAC1 protein was elevated in
AdHDACwt infected cells, the corresponding increase tant in early steps of virus replication [16]. There is also
evidence that viral gene repression during herpes virusin deacetylase activity was not observed. Because a
slight amount of CELOdG replication can be stimulated latency involves histone deacetylation [17]. However,
blocking deacetylase activity may have negative conse-by the adenovirus vector itself (the passageable lucifer-
ase levels obtained with AdEGFP complementation are quences for the virus: inhibiting deacetylase has been
shown to activate cellular mechanisms to combat thedetectably above background), we asked if an indepen-
dent and nonviral method of blocking HDAC activity viral infection [18], and this must be balanced against
any transcriptional advantages the virus obtains withcould replace Gam1 function. We find that application of
the deacetylase inhibitor TSA at each passage allowed this function. Future experimental work will determine
if manipulating the acetylase/deacetylase pathway canCELOdG replication (Figure 4B). Thus, two distinct
methods of interfering with HDAC activity can be used lead to useful antiviral therapies.
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Figure 3. Mapping HDAC1 Interaction Domain; Gam1 Interacts In Vitro with GST-HDAC1, 2, and 3 and Binds the Amino-Terminal 53 Amino
Acids, a Region Common to These Three HDACs
(A) Cartoon of the GST-HDAC1 constructs used to identify the region in HDAC1 required for Gam1 binding. Numbers indicate amino acid
position defining each deletion construct; GST is a shaded box. Gam1 binding is summarized on the right of the panel.
(B) Equal amounts of the indicated bacterially expressed GST-HDAC1 constructs or GST alone were incubated with in vitro translated
radiolabeled Gam1. Lane 1: 20% of the input protein in each binding reaction; lane 2: GST alone; lane 3: full-length GST-HDAC1; lane 4: GST-
HDAC1, 1–53; lane 5: GST-HDAC1, 54–303; lane 6: GST-HDAC1, 303–482.
(C) Coomassie blue staining pattern of (B).
(D) Equal amounts of bacterially expressed GST-HDAC1 (lane 1), GST-HDAC2 (lane 2), and GST-HDAC3 (lane 3) fusion proteins were incubated
with 10 l of in vitro translated radiolabeled Gam1 as described in Experimental Procedures. GST alone was included as a negative control
(lane 4) and 1/10 of the amount used in the binding reaction loaded on the input lane (lane 5).
(E) Coomassie blue staining pattern of (D).
(F) Equal amounts of GST-Gam1, GST-Gam1mt, and GST alone were incubated with total protein extract from logarithmically growing Swiss
3T3 cells, washed, and tested for HDAC binding (see Experimental Procedures). Expression levels of endogenous HDAC1 and the GST constructs
were determined by immunoblot (anti-HDAC1 and anti-GST antibodies). Lane 1, GST-Gam1; lane 2, GST-Gam1mt; lane 3, GST alone.
(G) Gam1 and HDAC1 associate in vivo. Whole-cell extracts were immunoprecipitated (IP) with anti-HDAC1 antibody, and Gam1 was visualized
by Western blot analysis with the anti-myc antibody. In the lower panel, expression levels of epitope-tagged constructs in the lysate were
determined by immunoblot (anti-myc antibody). U2OS and Hela cells were transfected with 5 g of the indicated plasmids. Lanes 1 and 5,
nontransfected cells (NT); lanes 2 and 6, empty vector (EV); lanes 3 and 7, myc-Gam1; lanes 4 and 8, myc-E1B 19K.
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